ADW-A TOR Week ended 31 Jul 2026

Weekly Investor Report

Andrew Peller Limited · Consumer Defensive · Beverages - Wineries & Distilleries

Open interactive chart View report data
Latest close 7.95 CAD
-0.4% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 33.0% above the Trend Line and sits at 98.7% of its 52-week range. The latest completed week returned -0.4%, after a 0.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 53/100. Near-term considerations: price is close to its 52-week high.

Setup score 77 out of 100
Latest Close 7.95 CAD 31 Jul 2026
1W Return -0.4% latest completed week
4W Return 0.3% short-term follow-through
12W Return 39.3% quarterly tape
Trend Breadth 96.2% 50 of 52 weeks active
Volume Ratio 1.8x vs 13-week average
What is working
  • The trend backdrop is active with a 29-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.4% Latest completed week; four-week move 0.3%. Indicator stack 98/81 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 53/100 19 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 33.0% above the Trend Line and sits at 98.7% of its 52-week range. The latest completed week returned -0.4%, after a 0.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9712-week average 0.96

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.97Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.3% over four weeks, 39.3% over 12 weeks, and 54.6% over one year. The current trend has remained active for 29 consecutive weeks.

Performance by holding period

1W-0.4%
4W0.3%
12W39.3%
26W53.8%
52W54.6%
Active trend streak29 weeks
Active weeks in one year50
Trend breadth96.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.57Latest activity-pressure read.
Pressure change29.4%Four-week change in activity pressure.
Leadership30.91Latest relative-leadership reading.
RS change-5.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength98/100Blend of value, momentum, and quality. Underlying universe rank 3; rank 1 is best.
Value95/100Relative valuation strength. Underlying universe rank 6; rank 1 is best.
Quality81/100Profitability and accounting quality. Underlying universe rank 20; rank 1 is best.
Momentum77/100Medium-term price momentum. Underlying universe rank 24; rank 1 is best.
Growth74/100Revenue and earnings growth. Underlying universe rank 27; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework68/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
12.9x
Price divided by trailing earnings.
Price / sales
0.9x
Market value relative to trailing revenue.
EV / EBITDA
7.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
11.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
42.4%
Gross profit retained from each unit of revenue.
Operating margin
11.4%
Operating profit retained from revenue.
Free-cash-flow margin
14.5%
Free cash flow generated from revenue.
Return on invested capital
8.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
0.9%
Latest one-year revenue growth.
EPS growth
140.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
34.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
3.1%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
3.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 19 relevant articles.

4 positive · 15 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-0.5%Distance below the 52-week high.
13-week volatility10.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher18 of 268 weeks finished lower.
Best week+39.4%Week of 19 Jun.
Worst week-3.1%Week of 15 May.
Latest week-0.4%Week of 31 Jul.

Shape of recent returns

Strong gains2
Modest gains16
Flat weeks0
Modest losses8
Sharp losses0
Recent vol10.5%13-week weekly-return volatility.
Base vol5.7%52-week weekly-return volatility.
Up/down split31/19Count of positive and negative weeks in the 52-week window.
Average skew2.7% / -1.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape78/100

Trend, activity pressure, participation, and risk combine to a 78/100 tape read.

 Indicator analysis79/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 7/12.

Activity pressure 0.97; 2 reversal markers Factors87/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 41; Small Cap Core rank 10 SVQF68/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 97.5 of 298 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment53/100

Weighted news tone is neutral across 19 relevant articles.

ISS Endorses Fairfax's $8.00 Per Share Arrangement for Andrew Peller Limited Going-Private Deal Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20267.95 CAD-0.4%5.98 CAD4.48 CAD1.5730.91454.9KOn
24 Jul 20267.98 CAD0.1%5.89 CAD4.45 CAD1.6231.39389.7KOn
17 Jul 20267.97 CAD0.1%5.79 CAD4.42 CAD1.5732.13344.8KOn
10 Jul 20267.96 CAD0.4%5.69 CAD4.39 CAD1.5632.41931.2KOn
3 Jul 20267.93 CAD0.5%5.59 CAD4.37 CAD1.2132.75615.8KOn
26 Jun 20267.89 CAD0.3%5.50 CAD4.34 CAD0.7833.6379.6KOn
19 Jun 20267.87 CAD39.4%5.40 CAD4.31 CAD0.6733.81130.8KOn
12 Jun 20265.65 CAD1.6%5.30 CAD4.28 CAD0.37-3.4714.1KOn
5 Jun 20265.56 CAD-1.6%5.29 CAD4.27 CAD0.36-3.764.9KOn
29 May 20265.65 CAD1.1%5.27 CAD4.25 CAD0.66-3.32114.0KOn
22 May 20265.59 CAD1.1%5.24 CAD4.24 CAD0.70-3.5759.1KOn
15 May 20265.53 CAD-3.1%5.22 CAD4.23 CAD0.94-2.8484.7KOn
8 May 20265.71 CAD2.5%5.21 CAD4.21 CAD1.27-0.43119.6KOn
1 May 20265.57 CAD-2.0%5.18 CAD4.20 CAD1.21-2.36117.0KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.